NASDAQ · Analyst Forecast

Jaguar Health, Inc. (JAGX) Stock Forecast & Price Target

$0.38 NASDAQ: JAGX Market Cap $5.07M

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 17, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Jaguar Health, Inc. (JAGX), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Jaguar Health, Inc., analysts forecast revenue falling from $10.60M in 2022 to $4.11M in 2027; the average estimate for 2027 earnings per share is −$102.53; 1 analyst contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$0.38
Consensus targetThe average of the price targets analysts have published.$3.21
Median targetThe middle target, less affected by a single outlier.$3.21
Highest targetThe most optimistic published target.$3.21
Lowest targetThe most pessimistic published target.$3.21
Difference from priceHow far the consensus target sits from today’s price.+744.7%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2022$10.37M$10.60M$10.83M1
2023$9.10M$9.32M$9.54M1
2024$11.30M$11.30M$11.30M1
2025$12.56M$12.56M$12.56M1
2026$2.46M$2.46M$2.46M1
2027$4.11M$4.11M$4.11M1

Earnings per share forecast

YearLowAverageHighAnalysts
2022−$3031875.00−$3031875.00−$3031875.001
2023−$306075.00−$306075.00−$306075.001
2024−$7594.77−$7594.77−$7594.771
2025−$4720.15−$4720.15−$4720.151
2026−$45.57−$45.57−$45.571
2027−$102.53−$102.53−$102.531

Jaguar Health, Inc. (JAGX) forecast — frequently asked questions

What is the analyst price target for Jaguar Health, Inc.?

Analysts covering Jaguar Health, Inc. (JAGX) have a consensus price target of $3.21, 744.7% above the current price of $0.38. Published targets range from $3.21 to $3.21. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Jaguar Health, Inc.'s earnings?

The average analyst estimate for Jaguar Health, Inc. (JAGX) earnings per share in 2027 is -102.53, with individual estimates between -102.53 and -102.53.

How much revenue is Jaguar Health, Inc. expected to make?

Analysts forecast Jaguar Health, Inc. (JAGX) revenue of $4.11M in 2027, based on 1 published estimates.

How many analysts cover JAGX?

1 analyst contribute estimates for Jaguar Health, Inc. (JAGX). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.